1 Oct 2025Open access
Multislice computed tomography imaging in the assessment of retroperitoneal cystic lesionsPublisher siteTanta Medical Journal, Intraperitoneal and Appendiceal Malignancies
Active, last published 2026
In hepatocellular carcinoma treatment and prognosis
Sherif Abdelfattah
Saber
Scholar“Research focused on Hepatocellular Carcinoma Treatment and Prognosis and adjacent fields.”
Claim Your Profile1
H-index
14
Citations
Sherif has not officially claimed their profile. If you are Sherif, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
herif Abdelfattah Saber is a researcher working on Hepatocellular Carcinoma Treatment and Prognosis. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Sherif's work has been cited 14 times across 1 active year. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
Hepatocellular Carcinoma Treatment and Prognosis×1
04 · Where I am
Affiliations
Affiliation on published researchTanta University Hospital, EgyptDrawn from the institution listed on this researcher’s published work.
Research themes (UN SDGs)
05 · Selected work
Recent publications
2 works1 Jul 2025Open access
Ultrasound versus Triphasic Computed Tomography Liver Imaging Reporting and Data System in Suspected Hepatocellular CarcinomaPublisher siteSVU-International Journal of Medical Sciences, Hepatocellular Carcinoma Treatment and Prognosis
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Sherif?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you